The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab
How clinical laboratories and pathology groups can ensure that their digital pathology and AI workflows are HIPAA-compliant
What labs need to know about keeping patients’ data safe when using digital pathology and artificial intelligence-based solutions